Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
A graphical look at some of the key changes to expect in industry fees and FDA performance commitments based on a draft deal to reauthorize the medical device user fee program (MDUFA VI).
This month, consumer tech giants acquire or partner to put core skill sets to use for medical applications; two private equity deals signal what's hot; and Curium, curiously, creates a radiopharmaceuticals giant.
The country amends its regulations to further rely on EU CE marks, and makes other simplifications. Excerpted from Pathways Picks August 26: India Harmonization, Digital Health Updates, FDA Home Challenge, and More.